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Abstract: Blood transfusion is often a life saving
intervention, butcanalsobeharmful.Restrictive trans-
fusion protocols have recently been developed with a
post transfusion target haemoglobin level of 70–100
g/l.Whetherhaemoglobin levelonitsownisenoughto
guide our transfusion policy is an important issue. This
review was aimed to look at other possible, so called
physiological indicators of blood transfusion what cli-
nicians can be used in addition to haemoglobin during
their everyday practice. In the second part of the paper
the problems of the management of massive bleeding
are reviewed. In both cases, a complex approach is re-
quired taking into consideration physiological changes
in order to individualize treatment and hence avoid
harm that can be caused by unnecessary transfusion of
blood products.
Key words: blood transfusion, transfusion triggers,
haemoglobin, central venous saturation.
INTRODUCTION
Blood transfusion can be on the one hand life-sa-
ving, while on the other hand it may be a dangerous
and expensive intervention. Untreated anaemia can be
associated with increased morbidity and mortality,
while transfusion may cause various infectious and
non-infectious adverseeffects(1,2,3).Despitethefact
that a number of alternative methods were tried and te-
sted in medicine, the transfusion of red blood cells still
remain essential in the everyday medical practice. A
number of guidelines are helpful in transfusion practi-
ce,butthecriteriafortheoptimalmanagementofanae-
mia are not clearly defined. One of the landmark studi-
esinthefield,theTRICC(Transfusion Requirement in
Critical Care) trial found no benefit with the use of a li-
beral transfusion strategy to maintain haemoglobin
(Hb) levels of 100 g/l as compared with a restrictive
approachwheretransfusionswereonlyindicatedtopa-
tients with a haemoglobin level < 70 g/l (2). Therefore
in most guidelines the transfusion trigger (the indica-
tion andtiming ofthenecessity ofblood transfusion) is
a certain level of haemoglobin, usually 70–100 g/l (4,
5). However, it raises a fundamental question, whether
thisgeneralconceptcanbeappliedforeverypatient,or
not?Therightansweriscertainly: no.Inordertodeter-
mine individualized transfusion triggers, we need to
considerphysiological indicatorsofbloodtransfusion.
ANAEMIAAND OXYGEN DEBT
Theadequacy oftissueoxygenation isdetermined
by the balance between the rate of oxygen transport to
thetissues(oxygendelivery,DO2)andtherateatwhich
the oxygen is used by the tissues (oxygen consump-
tion, VO2) (6). Standard formulae to determine oxygen
delivery and oxygen consumption are:
DO2= SV x HR x ŠHb x 1.34 x SaO2 + 0.003 x
x PaO2¹ = CO x ŠCaO2¹
VO2=COxŠCaO2–(Hbx1.34xSvO2+0.003x
x PvO2)¹ = CO x ŠCaO2 – CvO2¹
DO2 — oxygen delivery, SV — stroke volume, HR
— heart rate, Hb — haemoglobin, SaO2 — haemoglo-
bin arterial oxygen saturation, PaO2 — arterial oxy-
gen partial pressure, CO — cardiac output, CaO2 —
arterial oxygen content, VO2 — oxygen consumption,
SvO2—haemoglobin mixed venous oxygen saturation,
PvO2—venousoxygen partial pressure,CvO2—veno-
us oxygen content.
From the above formula oxygen delivery for an
average adult at rest can be calculated:
CO = 70 mL x 72/min = 5 L/min
CaO2 = (150 g/L x 1.34 mL x 1) +
+ (0.003 x 100 mm Hg) = 201.3 mL/L
DO2 ¬ 1000 mL/min
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CvO2 = (150 g/L x 1.34 mL x 0.75) +
+ (0.003 x 40 mm Hg) = 150.87
VO2 = 5L/min x ( 201.3 mL/L – 150.87 mL/L) ¬
¬ 250 mL/min
Oxygen extraction (VO2/DO2 x 100) =
= 250 mL/min / 1000 mL/min x 100 = 25 %
In the critically ill there is often an imbalance bet-
ween delivery and consumption: DO2 may be too low
for several reasons (hypovolaemia, bleeding, pump fa-
ilure, etc.), and frequently accompanied by increased
VO2 (agitation, fever, pain, etc.). The circulation can
compensate to some extent, but after a critical thresh-
old severe oxygen debt and shock may occur (7).
One of the most common causes of inadequate
DO2 in the intensive care unit is anaemia requiring red
blood cell transfusions (8). It has recently been sugge-
sted that haemoglobin level should not be the only fac-
tor on which the indication of the need for transfusion
is based (4, 5). According to the TRICC trial, patients
with haemoglobin level above 100 g/l require rarely
transfusion while red blood cell donation is usually ne-
cessary if haemoglobin is below 70 g/l. There is howe-
ver a clear need for additional parameters in patients
with haemoglobin level between 70 and 100 g/l. Clini-
cians utilize different tools from simple clinical signs
(confusion, tachycardia, ST-segment elevation/depres-
sion, diuresis) to invasive hemodynamic measure-
ments (central venous oxygen saturation, oxygen ex-
traction, central venous-to-arterial carbon dioxide dif-
ference) in order to have information on anaemia rela-
ted altered oxygen extraction and hence the need for
blood administration (9). One of the potentially useful
physiological parameters is the central venous oxygen
saturation (ScvO2).
CENTRALVENOUS OXYGEN
SATURATION (ScvO2)
AS ATRANSFUSION TRIGGER
ScvO2 is an easily obtained parameter via the cen-
tral venous catheter already in situ in most critically ill
patients and it is often used as a marker of the balance
between oxygen delivery and consumption. The nor-
malvalueofScvO2variesbetween73–82%(10,11).It
isslightly higherthanmixed-venous oxygensaturation
(SvO2), and is considered a reasonable surrogate mar-
ker in the clinical setting (9). The main factors, which
influence ScvO2 are haemoglobin, arterial oxygen sat-
uration of haemoglobin, cardiac output and oxygen
consumption. Theoretically if three of these factors are
keptconstantthevalueofScvO2reflectsthechangesof
the latter.
It was found during haemorrhage in animal and
human experimental models that ScvO2 may be useful
for the identification of patients with occult or ongoing
clinically significant blood loss (12, 13). In bleeding
conditions, an ScvO2 value of ¬70% has been used as a
goal to therapeutic intervention in attempts at impro-
vingoxygendelivery(9).Inaprospectivehumaninter-
ventional study it was found that in acute isovolaemic
anaemia with a haemoglobin 50 g/L in conscious he-
althyrestinghumansdidnotproducehemodynamicin-
stability, but oxygen imbalance was accompanied by a
significant drop in mixed venous saturation (14). The-
seresultswerereinforcedbyaretrospective analysisof
a prospective observational study in which ScvO2 was
found to be a good indicator of transfusion (15). The
results of our animal study on isovolaemic haemodilu-
tion give further evidence that anaemia-induced chan-
geinoxygenbalancecanbemonitoredbyScvO2(16).
According to the above mentioned studies it se-
ems that ScvO2 better identifies the point when com-
pensatory mechanisms failand oxygen delivery begins
to decline, as compared to the Hb concentration alone.
A “low” level of Hb does not necessarily lead to oxy-
gen debt in haemodinamically stable, anesthetized,
ventilated patients,whileoxygenimbalancemayoccur
in agitated, pyrexial patients with “normal” hemoglo-
bin level. These findings are in accord with the idea
that compensatory changes in cardiac output and other
parameters of oxygen delivery make haemoglobin
concentration alone a less sensitive marker of oxygen
balance and for the need for therapeutic intervention to
increase DO2. ScvO2 could therefore be important in
helping to avoid hypoxia and tissue injury under such
circumstances, while helping to more accurately guide
blood transfusions.
Therefore we believe that not only the haemoglo-
bin level, but ScvO2 and other signs of oxygen debt
(confusion, angina, low diuresis, serum lactate level
etc.) should be taken into account before using red
blood cells in order to reduce the number of unneces-
sary transfusion. Protocolising transfusion and adopt-
ingprotocols foreverypatient isthereforedifficult,be-
cause of its multimodal features. Nevertheless, apply-
ing the above mentioned approach of including physi-
ological indicators ofoxygen debt inthe decision mak-
ingmayhelpusinindividualizing transfusiontherapy.
MASSIVE TRANSFUSION
Uncontrolled haemorrhage and massive transfu-
sion are frequent complications of trauma and surgery
(17). Massive transfusion has been defined commonly
as a transfusion of greater than 10 unit of packed red
bloodcellsorthereplacementofonebloodvolumeina
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sion, such as the transfusion of four or more red cell
concentrateswithin1hwhenongoingneedisforeseea-
ble, or the replacement of 50% of the total blood volu-
mewithin 3h, ismorerelevant in the acute clinical set-
ting (18).
Acoordinated teamwork is essential in the mana-
gement of a patient requiring a considerable amount of
blood products. The interdisciplinary group should in-
clude emergency physicians, anaesthetists, surgeons,
haematologists, interventional radiologists and labora-
tory staff. The management of the patient who is being
massively transfused requires careful and ongoing
consideration of a number of complex physiological
relationships. The keystones of the treatment are the
following: attenuation of bleeding, improvement of
tissue oxygenation by correction of blood volume with
appropriate amounts and types of blood components
and fluids, management of coagulation abnormalities
and changes in ion and acid-base balance (19).
Several clinical studies have demonstrated that the
institution of hospital-specific massive transfusion pro-
tocols(MTP)maypromotetheinterdisciplinaryco-ope-
ration, accelerate the patient care and thereby improve
the outcome of patients with severe bleeding (20).
1. Attenuation of bleeding
Identifying the source of bleeding and definitive
haemorrhage control areessential components oftreat-
ment.Rapid,externalbloodlosscanbemanagedbydi-
rect manual pressure on the wound. Pneumatic splint-
ing devices — especially in prehospital care — also
canhelptocontrolhaemorrhage.Tourniquetsareinfre-
quently used in severe bleeding. Definitive control in-
clude surgery, angioembolization, endoscopic control
in some gastrointestinal bleeding and pelvic stabiliza-
tion. Aggressive and continued volume resuscitation is
not a substitute for control of haemorrhage. During the
attenuation of bleeding permissive hypotension is also
recommended (systolic pressure of 80 mmHg, systolic
pressureof100mmHginheadinjury)although thereis
no consensus on its general use (21).
2. Fluid resuscitation
Uncontrolled bleeding leads to a combination of
hypovolaemia and anaemia. Hypovolaemia — caused
by decreased blood volume — may lead to hemodyna-
mic instability (low arterial blood pressure and/or car-
diac output) thereby worsening oxygen-carrying capa-
city of the blood. Anaemia — caused by haemoglobin
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Figure 1. The massive transfusion protocoldeficiency — reduces arterial blood oxygen content,
thus further enhancing the oxygen debt (22).
Atrest,oxygendeliveryisnormallyfourtimeshig-
her than oxygen consumption, indicating the presence
of a moderate reserve. Thus, if intravascular volume is
maintained during bleeding (isovolaemic haemodilu-
tion) and cardiovascular status is not impaired, oxygen
delivery may remain adequate because elevated cardiac
output plus increased oxygen extraction can compensa-
te for the decrease in arterial oxygen content (16).
After manifestation of macro-hemodynamic chan-
ges and developing of hypoperfusion, the microcircu-
lation may also be damaged. At the cellular level, due
to inadequate perfusion and oxygenation cells are de-
prived of essential substrates for normal aerobic meta-
bolism and energy production. Anaerobic metabolism
occurs,whichresultsintheformationoflacticacidand
the development of metabolic acidosis. If shock is pro-
longed thecellular energy-consuming enzyme systems
are exhausted, the cellular membrane loses the ability
to maintain its integrity. If the process is not reversed,
progressive cellular damage and organ failure occur.
Without reversing the process, it ultimately leads to de-
ath (23).
Correction ofthe deficit in blood volume with flu-
ids will generally maintain hemodynamic stability and
cardiac output, while transfusion of red cells is used to
improve oxygen content of blood in order to optimize
tissue oxygenation. Each unit of packed cells contains
approximately 200 ml of red cells and, in an adult, will
raise the haematocrit by roughly 3 to 4 percentage po-
ints unless there is continued bleeding (24).
The concept of the treatment of massive bleeding
is summarized in Figure 1 (25).
3. Management of coagulation
abnormalities
Theonsetandseverityofcoagulopathy associated
with massive transfusion differsdepending on whether
haemorrhage occurs as a result of trauma or elective
surgery. In trauma patients, tissue trauma is uncontrol-
led, the interval between injury and definitive treat-
ment can vary widely (17). Therefore hypovolaemia,
hypoperfusion, and lactate acidosis and hypothermia
occurfrequently.Duetotissuedamage,vascularinjury
and systemic hypoperfusion high amounts of protein
C, thrombomodulin and tissue plasminogen activator
(tPA)arereleased fromendothelial cell creating hyper-
fibrinolysis and anticoagulant state (26). Hypothermia
compromises platelet adhesion and enhances clot lysis
(27). Acidosis affects the activity of coagulation fac-
tors and alters platelet function (28). Initial resuscita-
tionisoftenachievedwithfluidscontaining noclotting
factors.Dilutionandconsumption ofremainingfactors
further diminish the haemostasis (29). Evolving coa-
gulopathy – called trauma-induced coagulopathy — is
often related to the development of disseminated intra-
vascular coagulation. Monitoring of haemostasis oc-
curs late, when coagulopathy is installed, and treat-
ment can be very difficult. Definitive control of bleed-
ing, early correction of hypoperfusion and efficient
re-warming are key elements of the treatment and can
prevent development or worsening of coagulopathy.
Recent studies suggest the “damage control resuscita-
tion” concept for treatment of trauma-induced coagu-
lopathy. The use of ration driven concept of FFP-RBC
in 1:1 ratio seemed to improve survival in severe blee-
ding in military and civil trauma (30). However, the re-
sultsofthesestudies areconflicting andmostofthetri-
als are retrospective and come from the military field.
Because of substantial differences between civilian
and military trauma (characteristics of the underlying
population, thenatureofthetrauma,andthetreatments
available)theresultsofthesetrialsshouldnotbeconsi-
dered immediately transferrable to civilian trauma pa-
tients (31).
In the context of elective surgery, tissue injury is
controlled bythesurgeonandremainslimited. Patients
at risk of haemorrhage are monitored extensively, pe-
ripheral and central venous accesses are secured, and
resuscitation with crystalloids and colloids is prompt.
Blood is available rapidly, if not immediately, and red
cells can be replaced, as needed, in a timely manner.
Except in the most extreme cases, shock and acidosis
canbeavoided. Withtheuseofmodernbodyandintra-
venous fluid warmers, hypothermia can also be avoi-
ded. Inthemajority ofelective surgical cases,coagulo-
pathy will, essentially, be secondary to the dilution of
coagulation factors (17, 32).
Asimplified approach forthe correction ofthe ha-
emostasis based on laboratory measurements is sum-
marised in Figure 2.
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Figure 2. A simplified approach to treat
hemostatic disorders4. Correction of ion imbalance
Plasmaionized calcium and potassium levels sho-
uld be periodically monitored, particularly in patients
with coexistent liver or renal disease or in those with
massive haemorrhage (33). Large amounts of citrate
are given with massive blood transfusion, since blood
is anti-coagulated with sodium citrate and citric acid.
Metabolic alkalosis and a decline in the plasma free
calcium concentration are the two potential complica-
tions of citrate infusion and accumulation (34).
Infants and patients with renal impairment may
develop hyperkalemia because of potassium leakage
due to prolonged blood storage or irradiation. In these
patients, using red cells collected less than five days
prior to transfusion or removing extracellular potassi-
um by washing any unit of red cells immediately befo-
re infusion can minimize the risk of hyperkalemia.
CONCLUSION
Blood transfusion in general and massive transfusion
even more so, hasbeen and will most probably alwaysbe
al i f es a v i n gi n t e r v e n t i o n .T h o r o u g hu n d e r s t a n d i n go ft h e
details of physiology of oxygen delivery and consump-
tion, hemodynamic changes during shock and trauma,
the coagulation cascade and so on, isofutmost importan-
ce. With the help of the above mentioned physiological
indicators we can supplement evidence based protocols,
and apply a safe, individualized care for our patients.
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Sa`etak
FIZIOLO[KI TRIGERI TRANSFUZIJE I MASIVNATRANSFUZIJA
Tanczos Krisztian, Molnar Zsolt
Department of Anaesthesia and Intensive Therapy, University of Szeged, Hungary
Transfuzijakrvije~estointervencija koja spasava
`ivot, ali tako|e mo`e biti i {tetna. Novi protokoli re-
striktivne transfuzije ukazuju na to da vrednosti cilj-
nog posttransfuzionog hemoglobina budu izme|u
70–100 g/l. Va`no pitanje je da li je nivo hemoglobina
sam po sebi dovoljan da bude rukovode}i pokazatelj
transfuzije. Ovaj rad ima za cilj da razmotri druge mo-
gu}nosti, takozvane fiziolo{ke indikatore transfuzije
krvi,kojiuzvrednosti hemoglobina, mogubitiodkori-
sti klini~kim lekarima u svakodnevnoj praksi. U dru-
gom delu rada su razmatrani problemi zbrinjavanja
masivnog krvarenja. Uoba slu~aja jeneophodan kom-
pleksan pristup, uz razmatranje i fiziolo{kih parameta-
ra, sa ciljem da se individualizuje tretman i izbegne
{teta koja mo`e biti prouzrokovana nepotrebnim tran-
sfuzijama krvi.
Klju~ne re~i: transfuzija krvi, trigeri transfuzije,
hemoglobin, centralna venska saturacija.
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